Kim Sharon, King Amanda, Parikh Pavan, Sangtani Ajleeta, Shazly Sherif, Brodrick Ellen, Thompson Angela
Division of Obstetrics, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota.
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Am J Perinatol. 2022 Mar;39(4):337-341. doi: 10.1055/s-0041-1739491. Epub 2021 Nov 28.
Optimal prescriptions practices of opioids in the post-cesarean period remain controversial. The primary aim of this initiative was to minimize unused prescription narcotic medication, with a goal of ≤4 leftover pills of 5-mg oxycodone at postoperative day (POD) 14 without affecting pain or satisfaction measures.
This was a prospective longitudinal quality improvement (QI) initiative starting in 2017 utilizing the DMAIC methodology. The measurement phase consisted of validated surveys over 3 months, along with chart review to determine current institutional prescription practices and predictors of outpatient opioid use. Resulting recommendations were adopted, and 1 year later, all patients undergoing cesarean were surveyed for 3 months to determine the effectiveness of the intervention. The study was approved by the Department's QI Committee.
The response rate was 48%, with 50 of 101 patients completing surveys pre-intervention and 52 of 111 post-intervention. Pre-intervention, surplus medication was predicted ( <0.05) only by the quantity of the opioid prescription. In addition, patients who required ≤37.5 morphine milligram equivalents (MMEs) during the inpatient postoperative stay did not require outpatient narcotic prescriptions. Thereafter, a strategy of matching inpatient use to outpatient prescription 1:1 in a linear regression model ( <0.001, 0.55) optimally matched patient needs up to 200 MME. In the post-intervention survey, mean (SD) prescription decreased from 17.6 (13.7) MME to 8.4 (8.3) MME ( <0.01); 39% compared with 16% of women were discharged without a prescription ( <0.01); and amongst all patients 82.7% compared with 59.6% ( <0.01) had ≤4 pills remaining without differences in patient satisfaction or pain perception.
This initiative highlights a practical approach to QI utilizing industry techniques in health care. This approach resulted in significant reductions in over-prescription and unused medication, without impacting pain or satisfaction scores.
· 20% of patients may manage pain at home without opioids.. · In-hospital opioid use is reflective of outpatient need.. · Customize prescriptions to reduce leftover narcotics..
剖宫产术后阿片类药物的最佳处方做法仍存在争议。该倡议的主要目标是尽量减少未使用的处方麻醉药物,目标是术后第14天5毫克羟考酮剩余药片≤4片,同时不影响疼痛或满意度指标。
这是一项从2017年开始的前瞻性纵向质量改进(QI)倡议,采用DMAIC方法。测量阶段包括为期3个月的经过验证的调查,以及病历审查,以确定当前的机构处方做法和门诊阿片类药物使用的预测因素。采纳了由此得出的建议,1年后,对所有接受剖宫产的患者进行了为期3个月的调查,以确定干预措施的有效性。该研究得到了该部门质量改进委员会的批准。
回复率为48%,101例患者中有50例在干预前完成了调查,111例患者中有52例在干预后完成了调查。干预前,仅根据阿片类药物处方的数量就能预测(<0.05)剩余药物情况。此外,术后住院期间所需吗啡毫克当量(MME)≤37.5的患者不需要门诊麻醉处方。此后,在一个线性回归模型中(<0.001,R²=0.55),将住院使用量与门诊处方按1:1匹配的策略能够最佳地满足患者高达200 MME的需求。在干预后的调查中,平均(标准差)处方量从17.6(13.7)MME降至8.(8.3)MME(<0.01);出院时未开处方的女性比例从39%降至16%(<0.01);在所有患者中,82.7%的患者剩余药片≤4片,而59.6%的患者剩余药片≤4片(<0.01),患者满意度或疼痛感知方面没有差异。
该倡议突出了一种在医疗保健中利用行业技术进行质量改进的实用方法。这种方法显著减少了过度处方和未使用的药物,同时不影响疼痛或满意度评分。
·20%的患者在家中无需使用阿片类药物即可控制疼痛。·住院期间阿片类药物的使用反映了门诊需求。·定制处方以减少剩余麻醉药品。